Tonix Pharmaceuticals Holding Corp
TNXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$173.28M
Close$
$13.54
39.6% upside
Current Fair Value
39.6% upsideUndervalued by 39.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $173.28 Million |
|---|---|
| Enterprise Value | $2.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.57 |
| Beta | 1.75 |
| Outstanding Shares | 16,635,254 |
Return
| Return on Equity | -50.73% |
|---|---|
| Return on Assets | -44.38% |
| Return on Invested Capital | -72.72% |
Valuation & Multiples
| P/E Ratio | -0.82 |
|---|---|
| PEG | - |
| Price to Sales | 9.7 |
| Price to Book Ratio | 0.75 |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.39 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-2.64
Average shareholder expectationRevenue Estimate
$7.72 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-2.45
Average shareholder expectationRevenue Estimate
$15.87 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.6019▲ 184.53% |
|---|---|
| Total Calls | 127,100▼ 17.73% |
| Total Puts | 330,700▲ 182.89% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.60%▲ 21.08% |
|---|---|
| Total Invested | $120.17M▲ 79.45% |
| Investors Holding | 109▲ 22.00% |
ESG Score
No data
About Tonix Pharmaceuticals Holding Corp
CEO: Seth Lederman